Clinical Trials Logo
  1. Home
  2. Calciphylaxis
  3. NCT02527213

Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath

Calciphylaxis Clinical Trial

Official title:
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment

Clinical Trial Summary

To evaluate the efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.

Clinical Trial Description

Efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02527213
Study type Interventional
Source Luitpold Pharmaceuticals
Contact
Status Terminated
Phase Phase 3
Start date January 30, 2015
Completion date August 29, 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01578382 - Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
Active, not recruiting NCT04592640 - Stem Cells for Uremic Calciphylaxis Patients N/A
Terminated NCT03319914 - Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Terminated NCT03150420 - A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients Phase 3
Completed NCT02790073 - Phase 2 Study With SNF472 in Calciphylaxis Patients Phase 2
Recruiting NCT03146793 - The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort N/A
Completed NCT02278692 - Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy N/A
Completed NCT02854046 - Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
Recruiting NCT03032835 - Partners Calciphylaxis Biobank
Completed NCT01289626 - Efficacy of Lanthanum Carbonate in Calciphylaxis Phase 1
Recruiting NCT06283589 - The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis Phase 1
Completed NCT04195906 - Phase 3 Study of SNF472 for Calciphylaxis Phase 3
Recruiting NCT02635373 - European Calciphylaxis Registry Network N/A
Recruiting NCT05018221 - Better Evidence and Translation for Calciphylaxis Phase 3